Menzaghi Frederique Ph.D. 4
4 · Cara Therapeutics, Inc. · Filed Dec 21, 2021
Insider Transaction Report
Form 4
Menzaghi Frederique Ph.D.
VP-Research & Development
Transactions
- Award
Common Stock
2021-12-17+12,607→ 153,679 total
Footnotes (1)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest as to (i) 50% on December 15, 2022; and (ii) 50% on June 15, 2023, subject to the Reporting Person's continued service with the Issuer through each such vesting date.